Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006196 · ClinicalTrials.gov registry record · Phase 1
The Relationship Between Vitamin D, Fingernail Thickness and Bone Density
A Phase 1 study of Osteoporosis, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT00006196: Completed Phase 1 study of Osteoporosis, sponsored by National Center for Research Resources (NCRR).
NCT00006196 is a Phase 1 study of Osteoporosis that has completed, run by National Center for Research Resources (NCRR). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006196, a Phase 1 study of Osteoporosis, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
Vitamin D deficiency is common in the elderly and contributes to the increased incidence of falls, hip fracture and depression in this population. An unknown number of elderly have vitamin D resistance resulting in a functional vitamin D deficiency state. Because there are no simple procedures or blood tests that identify vitamin D resistance, its prevalence and contribution to disability in the elderly is unknown. Our inability to screen for this condition precludes our ability to initiate and monitor treatment. Previous studies indicate that fingernail thickness correlates with vitamin D status and may therefore provide a simple cost effective procedure to not only identify patients with vitamin D deficiency but also, those with vitamin D resistance. This procedure may also provide a way to monitor an individual's response to treatment. This study is designed to demonstrate the association between fingernail thickness and vitamin D status.
Conditions Studied
Interventions
- DRUG Vitamin D
Study Locations (1)
Missouri
- 4488 Forest Park, Suite 201 - St Louis
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00006196 record still lists
NCT00006196 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D is the first listed.
NCT00006196 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00006196 about?
NCT00006196 is a clinical study titled "The Relationship Between Vitamin D, Fingernail Thickness and Bone Density". Vitamin D deficiency is common in the elderly and contributes to the increased incidence of falls, hip fracture and depression in this population. An unknown number of elderly have vitamin D resistance resulting in a functional vitamin D deficiency state. Because there are no simple procedures or bl...
What is the current status of trial NCT00006196?
This trial is currently completed. It is a Phase 1 study.
What conditions does trial NCT00006196 study?
This clinical trial studies the following conditions: Osteoporosis.
What interventions are being tested in trial NCT00006196?
The interventions under investigation include: Vitamin D (DRUG).
Who is sponsoring clinical trial NCT00006196?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006196 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
ACTIVE NOT RECRUITING · Phase 1
-
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
COMPLETED · Phase 1
-
Patient- and Physician-Based Osteoporosis Education
COMPLETED · Phase 1
-
Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects
COMPLETED · Phase 1
-
Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study
COMPLETED · Phase 1
-
A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women
COMPLETED · Phase 1